Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Inactivated whole Human Poliovirus serotype 1 antigen |
Is a |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Inactivated whole Human Poliovirus serotype 2 antigen |
Is a |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Inactivated whole Human Poliovirus serotype 3 antigen |
Is a |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Inactivated whole Human poliovirus antigen only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
Acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B and inactivated whole Human poliovirus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and inactivated Human poliovirus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Acellular Bordetella pertussis, Clostridium tetani toxoid, Corynebacterium diphtheriae toxoid, Haemophilus influenzae type b conjugated, Hepatitis B virus and inactivated Human poliovirus antigens only pediatric vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
6 |
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Inactivated whole Human poliovirus antigen |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
6 |